Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Thu, 13th Nov 2014 06:14

Thursday, November 13 
London Stock Exchange GroupHalf Year Results
Rolls-Royce HoldingsInterim Management Statement
Premier OilInterim Management Statement
Spirent CommunicationsInterim Management Statement
New World ResourcesQ3 Results
Catlin GroupQ3 Results
3i GroupHalf Year Results
WS AtkinsHalf Year Results
ElectrocomponentsHalf Year Results
Great Portland EstatesHalf Year Results
RexamInterim Management Statement
NorcrosHalf Year Results
Ted BakerInterim Management Statement
Trinity MirrorInterim Management Statement
UTV MediaInterim Management Statement
Vedanta ResourcesHalf Year Results
SABMillerHalf Year Results
Genel EnergyInterim Management Statement
ITVInterim Management Statement
SOCO InternationalInterim Management Statement
Volex GroupHalf Year Results
Infinis EnergyInterim Results
Friday, November 14 
IMIInterim Management Statement
AggrekoInterim Management Statement
Premier FarnellInterim Management Statement
Hill & Smith HoldingsInterim Management Statement
Macfarlane GroupInterim Management Statement
New Star Investment TrustInterim Management Statement
Capital Gearing TrustInterim Management Statement
RecordHalf Year Results
RotorkInterim Management Statement
Stanley Gibbons GroupHalf Year Results
CentaminQ3 Results
CastingsInterim Results
The Restaurant GroupInterim Management Statement
Monday, November 17 
MITIEHalf Year Results
DiplomaFull Year Results
LatchwaysHalf Year Results
KellerInterim Management Statement
Schroder Real Estate Investment TrustHalf Year Results
Irish Continental GroupInterim Management Statement
BodycoteInterim Management Statement
Tuesday, November 18 
Enterprise InnsFull Year Results
Balfour BeattyInterim Management Statement
British LandHalf Year Results
PaceInterim Management Statement
PrudentialInterim Management Statement
CarcloHalf Year Results
CML MicrosystemsHalf Year Results
DRS Data & Research ServicesInterim Management Statement
EasyjetFull Year Results
Enterprise InnsFull Year Results
HalmaHalf Year Results
Headlam GroupInterim Management Statement
HomeserveHalf Year Results
SepuraHalf Year Results
Vectura GroupHalf Year Results
UK Mail GroupHalf Year Results
Intermediate Capital GroupHalf Year Results
Cineworld GroupInterim Management Statement
Picton Property IncomeHalf Year Results
Lavendon GroupInterim Management Statement
Intertek GroupInterim Management Statement
McKay SecuritiesHalf Year Results
BBA AviationInterim Management Statement
Waterman GroupInterim Management Statement
Wednesday, November 19 
Telecom PlusHalf Year Results
Royal Mail GroupHalf Year Results
Avon RubberFull Year Results
ICAPHalf Year Results
Big Yellow GroupHalf Year Results
ChesnaraInterim Management Statement
Ark Therapeutics GroupInterim Management Statement
DialightInterim Management Statement
AmlinInterim Management Statement
Ultra ElectronicsInterim Management Statement
Melrose IndustriesInterim Management Statement
HICL Infrastructure Co LtdHalf Year Results
OptosFull Year Results
Exova GroupInterim Management Statement
  
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
25 Jan 2017 07:48

Vectura sales trigger $5m milestone receipt

(ShareCast News) - Vectura said on Wednesday that a sales milestone receipt of $5m has been triggered following confirmation by Novartis that EU/Rest of World combined net sales of its Seebri Breezhaler and Ultibro Breezhaler for the year to the end of December have reached $512m. The milestone will

Read more
24 Jan 2017 08:21

Vectura gets FDA investigational approval for VR647

(ShareCast News) - Device and formulation business for inhaled airways disease, Vectura Group, announced on Tuesday it has received an 'Investigational New Drug' approval from the US Food and Drug Administration for its VR647 product. The FTSE 250 firm said the approval will allow it to conduct a Ph

Read more
24 Jan 2017 07:47

Vectura Gets US Approval For Phase I Trial Of Asthma Treatment

Read more
11 Jan 2017 08:25

Vectura makes 'significant progess' in third quarter

(ShareCast News) - Inhaled airways disease device and formulation business Vectura Group announced an unaudited pre-close update on Wednesday, ahead of its results for the nine months to 31 December, due in March. The FTSE 250 company said that following the step-change in financial performance anno

Read more
11 Jan 2017 07:58

Respiratory Medicine-Maker Vectura Breathing Easy Over Revenue Targets

Read more
23 Dec 2016 10:03

WINNERS & LOSERS SUMMARY: PayPoint Sale And Special Payout Lift Shares

Read more
23 Dec 2016 07:57

Vectura Group signs development agreement with Mundipharma

(ShareCast News) - Inhaled airways disease device and formulation business Vectura Group announced on Friday that it has signed a development and licence agreement with Mundipharma International Corporation and a US independent associated company as the global development and commercialisation partn

Read more
22 Dec 2016 14:57

Vectura says Bayer completes EU approval procedure for alternative nebulised delivery

(ShareCast News) - Vectura said on Thursday that its partner Bayer has confirmed completion of the EU regulatory procedure that allows an alternative nebulised delivery for its currently-marketed product Ventavis using the London-listed company's smart nebuliser Fox device. Ventavis has been develop

Read more
21 Dec 2016 14:15

Vectura says Novartis signs US licensing agreement for COPD treatments

(ShareCast News) - Vectura announced that Swiss pharmaceutical company Novartis has signed a licensing agreement with Sunovion Pharmaceuticals for the US commercialisation rights to three treatments for chronic obstructive pulmonary disease for which it receives royalty revenues. Novartis, whose pro

Read more
8 Dec 2016 07:57

Vectura confirms positive study results for Ultibro Breezhaler

(ShareCast News) - Inhaled airways disease-focused business Vectura Group confirmed an announcement by its partner Novartis on Thursday. The FTSE 250 firm said the announcement was of positive results from the first large-scale study exploring the effects of directly switching symptomatic, non-frequ

Read more
23 Nov 2016 07:40

Vectura earnings surge as Skyepharma merger creates step-change

(ShareCast News) - Inhaler maker Vectura's interim revenue have soared following the merger with rival Skyepharma and a launch of new products. For the six months ended 30 September, revenue increased 183% to £73.9m, compared to the same period last year, primarily due to the completion of the £441m

Read more
22 Nov 2016 07:41

TOP NEWS: Hikma Signs Development And Licensing Deal With Vectura

Read more
20 Nov 2016 15:57

Sunday newspaper round-up: OBR, Saudi Aramco, Tesco, BAT, bonds vigilantes

(ShareCast News) - The Office for Budget Responsibility is likely to cut its forecast for UK growth next year by the biggest margin since the peak of the eurozone debt crisis. Philip Hammond's Autumn Statement this week will see the Chancellor set out his multi-billion pound infrastructure plans and

Read more
17 Nov 2016 17:10

LONDON MARKET CLOSE: Strong US Data, Yellen Comments Point To Fed Hike

Read more
26 Oct 2016 14:14

Vectura climbs on positive read-across from Novartis, Singer upgrade

(ShareCast News) - Shares in medical device group Vectura were given a boost by expectations of foreign currency gains and investors reading across results from Novartis, with which the London-listed company is partnered on a handful of products. A third-quarter update from Novartis on Tuesday in

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.